1. Home
  2. TENX vs MYND Comparison

TENX vs MYND Comparison

Compare TENX & MYND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TENX
  • MYND
  • Stock Information
  • Founded
  • TENX 1967
  • MYND 1998
  • Country
  • TENX United States
  • MYND United States
  • Employees
  • TENX N/A
  • MYND N/A
  • Industry
  • TENX Biotechnology: Pharmaceutical Preparations
  • MYND Other Consumer Services
  • Sector
  • TENX Health Care
  • MYND Real Estate
  • Exchange
  • TENX Nasdaq
  • MYND Nasdaq
  • Market Cap
  • TENX 25.0M
  • MYND 27.6M
  • IPO Year
  • TENX N/A
  • MYND 2017
  • Fundamental
  • Price
  • TENX $5.99
  • MYND $0.59
  • Analyst Decision
  • TENX Strong Buy
  • MYND
  • Analyst Count
  • TENX 3
  • MYND 0
  • Target Price
  • TENX $15.00
  • MYND N/A
  • AVG Volume (30 Days)
  • TENX 15.7K
  • MYND 68.7K
  • Earning Date
  • TENX 08-13-2025
  • MYND 08-27-2025
  • Dividend Yield
  • TENX N/A
  • MYND N/A
  • EPS Growth
  • TENX N/A
  • MYND N/A
  • EPS
  • TENX N/A
  • MYND N/A
  • Revenue
  • TENX N/A
  • MYND $209,800,000.00
  • Revenue This Year
  • TENX N/A
  • MYND N/A
  • Revenue Next Year
  • TENX N/A
  • MYND N/A
  • P/E Ratio
  • TENX N/A
  • MYND N/A
  • Revenue Growth
  • TENX N/A
  • MYND N/A
  • 52 Week Low
  • TENX $3.25
  • MYND $0.53
  • 52 Week High
  • TENX $7.89
  • MYND $3.89
  • Technical
  • Relative Strength Index (RSI)
  • TENX 51.19
  • MYND 40.37
  • Support Level
  • TENX $5.88
  • MYND $0.56
  • Resistance Level
  • TENX $6.02
  • MYND $0.72
  • Average True Range (ATR)
  • TENX 0.13
  • MYND 0.05
  • MACD
  • TENX -0.01
  • MYND 0.01
  • Stochastic Oscillator
  • TENX 70.37
  • MYND 30.53

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

About MYND Mynd.ai Inc.

Mynd.ai Inc is a company that provides a platform for delivering digital content in K-12 classrooms, giving teachers seamless connectivity to inspire young minds. It features agnostic hardware that integrates across technology providers. Its product line includes a wide range of interactive tools and technologies, with its award-winning interactive displays at the forefront. It also offers interactive software apps such as Screen Share, computing modules, and accessories that meet the needs of customers, including K -12 educators, colleges and universities, small businesses and corporations, government agencies, and more. Geographically, it operates in United States and Rest of the world.

Share on Social Networks: